Here are three insights:
1. While Medtronic confirmed the purchase, the acquisition costs were not disclosed. Market analyst estimate the purchase was around $44.8 million.
2. Cropson develops minimally invasive medical devices to treat and diagnose gastrointestinal disorders.
3. Medtronic plans to use the acquisition to expand its existing GI portfolio to include solutions for oesophageal disease.
More articles on devices and implants:
Most orthopedic device educational material overly complex for patients — 4 insights
Smith & Nephew, Stryker & more: 7 device company mergers, acquisitions & agreements
Intuitive Surgical leads global robotic surgical market with da Vinci line: 4 observations
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
